NCT01824225View on ClinicalTrials.gov

Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2015

Conditions
Age-related Macular Degeneration
Interventions
DRUG

Aflibercept

Trial Locations (1)

101-8309

Surugadai Nihon university hospital, Chiyoda-ku

All Listed Sponsors
lead

Nihon University

OTHER

NCT01824225 - Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration | Biotech Hunter | Biotech Hunter